Today, US-regulated INJ futures began trading on Bitnomial Exchange, a CFTC-regulated designated contract market. For the first time, institutional and retail traders in the United States have a regulated derivatives product for Injective.
Hedge funds, prop desks, family offices, and eventually retail traders through Bitnomial's Botanical platform can now acquire INJ exposure, hedge existing positions, or build portfolio strategies through a regulated venue. No direct token custody required.
What This Unlocks
Until today, U.S. institutions that wanted INJ exposure had limited options. Most regulated allocators can't hold tokens directly. Compliance rules, custody requirements, and internal risk mandates make spot crypto difficult for traditional firms to touch.
Regulated futures solve that. A CFTC-regulated contract gives institutional traders a familiar instrument with clearing, margin, and counterparty protections already built in. The same infrastructure they use for commodities, rates, and equities now applies to INJ.
Retail traders get access soon. Botanical, Bitnomial's retail trading platform, will open INJ futures in the coming weeks. That creates a single regulated venue where both sides of the market can operate.
The Path to an Injective ETF
The futures listing starts a clock. Under the SEC's generic listing standards approved in September 2025, a commodity-backed exchange traded product can list without individual SEC review once its underlying asset has had futures on a CFTC-regulated market for at least six months.
Canary Capital has already filed an S-1 with the SEC for a staked INJ ETF, proposed to list on Cboe BZX Exchange. BitGo Trust Company as custodian. U.S. Bancorp Fund Services as transfer agent. Cboe filed the corresponding 19b-4 listing application in July 2025.
The staking component sets it apart from most crypto ETF proposals. The fund would stake its INJ holdings, generating yield on top of price exposure. A staking-enabled fund on a blockchain designed from the ground up for finance is a different proposition than a passive tracker on a general-purpose chain.
How the INJ Futures Contract Works
INJ futures settle in the underlying token with monthly expirations. Traders can post cryptocurrency or U.S. dollars as margin through Bitnomial Clearinghouse, which means they don't need to liquidate existing crypto positions to open an INJ trade. That's capital efficiency that cash-only venues can't match.
Bitnomial plans to add INJ perpetual futures and options after the standard monthly contracts. Perpetuals give traders continuous exposure without rolling expirations, a format that already dominates crypto derivatives volume globally. Options add structured hedging for larger positions. Together, these products will build a full regulated derivatives stack around INJ.
Injective Enters a New Regulated Tier of Acceptance
CME Group lists futures for Bitcoin, Ether, Solana, and other major top 20 crypto assets. Bitnomial has added regulated futures for a handful of digital assets over the past year. INJ now sits in that select group.
This matters because institutional allocators use a simple filter. If an asset doesn't have regulated derivatives infrastructure, it doesn't make the shortlist. Futures are the entry ticket. INJ now has one.
Validators running on Injective, like Google Cloud and Binance, already signal institutional confidence in the network itself. Regulated futures extend that confidence to the trading layer. All together with CFTC-regulated futures, institutional-grade validators, and an active ETF filing the opportunities begin to take shape.
Injective: Designed for Institutional Adoption
Injective is a Layer 1 blockchain built for finance. The network runs an onchain order book with sub-second finality and connects natively to IBC, Ethereum, and Solana. In November 2025, Injective shipped a real-time EVM mainnet that expanded access and compatibility for users, developers, and institutions to use and build highly performant onchain solutions.
That architecture is why regulated products are forming around INJ specifically. Onchain orderbooks, cross-chain settlement, near-zero gas fees. Injective was designed for financial applications, and the regulated market is now building the offchain infrastructure to match.
What Traders can do Today
Institutional clients can trade INJ futures on Bitnomial Exchange now. Retail access through Botanical follows in the coming weeks. Contracts are available through Bitnomial’s FCM clearing members.
The INJ futures are live. CFTC-regulated Perpetuals and options are next. The ETF filing is active. INJ is one of a small number of digital assets with all of this happening at once.
About Injective
Injective is a lightning fast interoperable layer one blockchain optimized for building premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps. INJ is the native asset that powers Injective and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by prominent investors such as Jump Crypto, Pantera and Mark Cuban.
Website | Telegram | Discord | Blog | Twitter | Youtube | Facebook | LinkedIn | Reddit | Instagram | Orbit Newsletter


